Literature DB >> 3723710

Use of oral contraceptives by women with epilepsy.

R H Mattson, J A Cramer, P D Darney, F Naftolin.   

Abstract

Oral contraceptives have not been associated with exacerbation of epilepsy despite warnings in package inserts. No clinical study has provided scientific evidence of worsening of seizures in epileptic women who use oral contraceptives, and improvement in seizure control has occurred in some cases. The main concern about use of oral contraceptives in this population is their effectiveness in preventing conception. Failure rates are higher in groups of women taking enzyme-inducing antiepileptic drugs. The degree of increased metabolism of estrogen and progestin components is highly variable and unpredictable among individuals. Use of higher doses increases protection against conception but also increases the risk of side effects, particularly in patients in whom no enzyme induction occurs. The strength of hormones in the pill should be selected individually when initiating use. Some women may require higher doses for full contraceptive effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723710

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

Review 1.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

2.  Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics.

Authors:  D J Back; S F Grimmer; M L Orme; C Proudlove; R D Mann; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

3.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

Review 4.  Treatment of epilepsy in pregnancy.

Authors:  I Nulman; D Laslo; G Koren
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 5.  Risk-benefit assessment of anticonvulsants in women of child-bearing potential.

Authors:  P G Cleland
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 6.  Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

Authors:  S M Grant; D Faulds
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 7.  Pregnancy, epilepsy, and anticonvulsants.

Authors:  Bernhard J Steinhoff
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 8.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 9.  Contraception for women with epilepsy: counseling, choices, and concerns.

Authors:  Arne Reimers
Journal:  Open Access J Contracept       Date:  2016-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.